Baidu
map

静脉输血后四级静脉炎,氧疗+水胶体贴敷轻松搞定!

2020-08-11 芳芳 护士网

静脉炎是静脉输液治疗最常见的并发症,发生率可达75%,严重者可发展为深静脉血栓、败血症等严重并发症。

静脉炎是静脉输液治疗最常见的并发症,发生率可达75%,严重者可发展为深静脉血栓、败血症等严重并发症。

相关研究报道,静脉炎的发生不仅增加患者的痛苦,延长住院时间,同时也增加了护士的工作量。

在此,与大家分享一例使用氧疗+水胶体透明贴治疗四级静脉炎的病例,希望给大家提供借鉴。

病例分享

基本资料:患者女性,77岁

入院诊断:急性心力衰竭、重度贫血、低蛋白血症、多浆膜腔积液。

发生及处理经过:2020-7-4 15:20 患者与左肘正中输注悬浮红细胞2个单位,结束后0.9%氯化钠注射液冲封管,于 7-5 该留置针通畅,穿刺处有血性渗出,予以更换3M贴膜后输注血栓通等常规药物,输液结束拔除该留置针,于 7-6 08:00 发现穿刺点出现脓性分泌物,并伴有以穿刺点为中心3*3cm的硬结,伴有疼痛。

局部处理:

1.先用碘伏消毒,范围超过硬结部位,防止穿刺点感染

2.待干后用0.9%氯化钠注射液冲洗碘伏,待干。

3. 取水胶体透明贴以穿刺点为中心,覆盖整个硬结部位(注意水胶体无张力贴敷,不利气泡,并用手掌轻轻按压片刻,是水胶体透明贴与皮肤完全贴合)。

4.嘱其抬高患肢。

治疗经过:7-7 16:00 发现水胶体内有脓性渗出,硬结大小无改变,仍有局部疼痛,遵医嘱更换更换敷料。

1. 先用碘伏消毒,范围超过硬结部位。

2.待干后用0.9%氯化钠注射液冲洗碘伏,待干。

3.给予高流量氧疗30分钟。

4. 取水胶体透明贴以穿刺点为中心,覆盖整个硬结部位(注意水胶体无张力贴敷,不利气泡,并用手掌轻轻按压片刻,是水胶体透明贴与皮肤完全贴合)。

5.嘱其抬高患肢。

7-9 15:00 水胶体内有少量脓性渗出,硬结范围较前缩小,仍有局部疼痛,遵医嘱更换更换敷料。

7-15-09:00 再次给予患者更换敷料,穿刺处无脓性分泌物渗出,局部硬结较前缩小,大小约0.5*0.7cm,患者自诉无疼痛,嘱其适当抬高患肢。

7-18 患者撤除敷料,穿刺点已愈合,局部无疼痛。

原因分析:①患者自身血管条件差,感知能力弱,未及时表达疼痛感;②该患者责任护士为低年资护士,对于输血后注意事项相对匮乏,护理组长对危重患者的病情把控不严;③穿刺点出现渗出时未及时上报上级护士,缺乏预见性思维。

经验总结:加强全员输血相关知识的培训,护理组长参与病情交接,为低年资护士把好关;提高预见性思维,工作中出现问题及时向上级护士报告。

总之,静脉炎作为静脉输液治疗中最常见的并发症之一,护理人员应采取积极有效的预防和处理措施,认真执行护理技术操作规范,减少静脉炎的发生,减轻静脉炎给患者带来的痛苦。

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1014726, encodeId=a6521014e26dd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4f54689743, createdName=pyunzhen, createdTime=Sun Sep 05 09:53:19 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698135, encodeId=95ea169813585, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Feb 03 02:34:29 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915740, encodeId=7a03915e406a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94395442894, createdName=班崽在线学习, createdTime=Tue Jan 12 00:43:05 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259730, encodeId=63721259e30e1, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423591, encodeId=532d1423591f8, content=<a href='/topic/show?id=e88d991535b' target=_blank style='color:#2F92EE;'>#静脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99153, encryptionId=e88d991535b, topicName=静脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50923807014, createdName=jichang, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466558, encodeId=f8dc1466558ff, content=<a href='/topic/show?id=621d6402097' target=_blank style='color:#2F92EE;'>#氧疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64020, encryptionId=621d6402097, topicName=氧疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a786841989, createdName=rgjl, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2021-09-05 pyunzhen

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1014726, encodeId=a6521014e26dd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4f54689743, createdName=pyunzhen, createdTime=Sun Sep 05 09:53:19 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698135, encodeId=95ea169813585, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Feb 03 02:34:29 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915740, encodeId=7a03915e406a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94395442894, createdName=班崽在线学习, createdTime=Tue Jan 12 00:43:05 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259730, encodeId=63721259e30e1, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423591, encodeId=532d1423591f8, content=<a href='/topic/show?id=e88d991535b' target=_blank style='color:#2F92EE;'>#静脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99153, encryptionId=e88d991535b, topicName=静脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50923807014, createdName=jichang, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466558, encodeId=f8dc1466558ff, content=<a href='/topic/show?id=621d6402097' target=_blank style='color:#2F92EE;'>#氧疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64020, encryptionId=621d6402097, topicName=氧疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a786841989, createdName=rgjl, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2021-02-03 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1014726, encodeId=a6521014e26dd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4f54689743, createdName=pyunzhen, createdTime=Sun Sep 05 09:53:19 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698135, encodeId=95ea169813585, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Feb 03 02:34:29 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915740, encodeId=7a03915e406a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94395442894, createdName=班崽在线学习, createdTime=Tue Jan 12 00:43:05 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259730, encodeId=63721259e30e1, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423591, encodeId=532d1423591f8, content=<a href='/topic/show?id=e88d991535b' target=_blank style='color:#2F92EE;'>#静脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99153, encryptionId=e88d991535b, topicName=静脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50923807014, createdName=jichang, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466558, encodeId=f8dc1466558ff, content=<a href='/topic/show?id=621d6402097' target=_blank style='color:#2F92EE;'>#氧疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64020, encryptionId=621d6402097, topicName=氧疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a786841989, createdName=rgjl, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2021-01-12 班崽在线学习

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1014726, encodeId=a6521014e26dd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4f54689743, createdName=pyunzhen, createdTime=Sun Sep 05 09:53:19 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698135, encodeId=95ea169813585, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Feb 03 02:34:29 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915740, encodeId=7a03915e406a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94395442894, createdName=班崽在线学习, createdTime=Tue Jan 12 00:43:05 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259730, encodeId=63721259e30e1, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423591, encodeId=532d1423591f8, content=<a href='/topic/show?id=e88d991535b' target=_blank style='color:#2F92EE;'>#静脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99153, encryptionId=e88d991535b, topicName=静脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50923807014, createdName=jichang, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466558, encodeId=f8dc1466558ff, content=<a href='/topic/show?id=621d6402097' target=_blank style='color:#2F92EE;'>#氧疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64020, encryptionId=621d6402097, topicName=氧疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a786841989, createdName=rgjl, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-08-13 windight
  5. [GetPortalCommentsPageByObjectIdResponse(id=1014726, encodeId=a6521014e26dd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4f54689743, createdName=pyunzhen, createdTime=Sun Sep 05 09:53:19 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698135, encodeId=95ea169813585, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Feb 03 02:34:29 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915740, encodeId=7a03915e406a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94395442894, createdName=班崽在线学习, createdTime=Tue Jan 12 00:43:05 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259730, encodeId=63721259e30e1, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423591, encodeId=532d1423591f8, content=<a href='/topic/show?id=e88d991535b' target=_blank style='color:#2F92EE;'>#静脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99153, encryptionId=e88d991535b, topicName=静脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50923807014, createdName=jichang, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466558, encodeId=f8dc1466558ff, content=<a href='/topic/show?id=621d6402097' target=_blank style='color:#2F92EE;'>#氧疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64020, encryptionId=621d6402097, topicName=氧疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a786841989, createdName=rgjl, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-08-13 jichang
  6. [GetPortalCommentsPageByObjectIdResponse(id=1014726, encodeId=a6521014e26dd, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4f54689743, createdName=pyunzhen, createdTime=Sun Sep 05 09:53:19 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698135, encodeId=95ea169813585, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Feb 03 02:34:29 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915740, encodeId=7a03915e406a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94395442894, createdName=班崽在线学习, createdTime=Tue Jan 12 00:43:05 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259730, encodeId=63721259e30e1, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423591, encodeId=532d1423591f8, content=<a href='/topic/show?id=e88d991535b' target=_blank style='color:#2F92EE;'>#静脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99153, encryptionId=e88d991535b, topicName=静脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50923807014, createdName=jichang, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466558, encodeId=f8dc1466558ff, content=<a href='/topic/show?id=621d6402097' target=_blank style='color:#2F92EE;'>#氧疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64020, encryptionId=621d6402097, topicName=氧疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a786841989, createdName=rgjl, createdTime=Thu Aug 13 09:34:29 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-08-13 rgjl

相关资讯

BMJ:强烈建议SpO2≥96%的患者停止氧疗

住了院,吸吸氧,很常见,但近日一份由国家专家小组发表在BMJ的指南指出,住院患者还是不推荐常规氧气治疗,认为获益不确定并有一定危害。

2017 ITS指南:急性临床治疗中氧疗的管理

2017年11月,爱尔兰胸科协会(ITS)发布了急性临床治疗中氧疗的管理指南,氧疗是急诊医疗中最常应用的治疗方式,该指南针对急诊医疗中氧疗应用的评估,监测以及停止等内容提出循证建议。

Eur Heart J:ST段抬高心肌梗死氧疗效果分析!

由此可见,接受PCI的STEMI患者常规吸氧并没有显著影响1年全因死亡、MI再住院、心源性休克或支架血栓形成。

Diabetes Care:伴有或不伴有糖尿病的心肌梗塞患者氧疗效果

由此可见,尽管伴有糖尿病的MI患者事件发生率明显较高,但氧疗并未显著影响1年全因死亡、心血管死亡或MI或者HF再入院,与基础糖尿病无关。

2018 临床实践指南:急性病患者氧疗

急性病患者氧疗指南针对急性病患者何时开始氧气治疗,接受氧疗的患者氧气流量的设置以及氧气饱和度的维持等内容提出建议。

Eur Respir J:采用10分钟的日间测试预测OSA患者对氧疗的反应性!

由此可见,觉醒状态下机械通气化学反射性检测可以被看作是一个简单的临床工具来预测OSA个体对吸氧治疗的反应。它可以为OSA的治疗提供一种新的个性化药物治疗方法。

Baidu
map
Baidu
map
Baidu
map